Browse Drug Recalls
942 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 942 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 942 FDA drug recalls in TX.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Mar 13, 2019 | fentaNYL 1000 mcg/100 mL Injectable Solution Fentanyl 0.9% Sodium Chloride, Q... | Lack of Assurance of Sterility | Class II | Advanced Pharma Inc. |
| Mar 13, 2019 | Morphine Sulfate 30 mg/30 mL (1 mg/mL) Injectable Solution Morphine Sulfate 3... | Lack of Assurance of Sterility | Class II | Advanced Pharma Inc. |
| Mar 11, 2019 | Volumex (Iodinated I 131 Albumin) Injection USP, 25 uCi per 1 mL syringe, Rx ... | Lack of Assurance of Sterility: preliminary environmental monitoring report exceeds limits, there... | Class II | Iso-Tex Diagnostics, Inc |
| Feb 6, 2019 | Fentanyl in 0.9% Sodium Chloride QS 0.5 mL, 5 mcg/0.5 mL with up to 0.1 mL of... | Labeling: Incorrect expiration date. | Class II | Advanced Pharma Inc. |
| Feb 6, 2019 | Oxytocin 10 Units added to NS 1000 mL (oxytocin and 0.9% Sodium Chloride) Inj... | Superpotent Drug: product may contain concentrations of oxytocin higher than what is represented ... | Class III | Advanced Pharma Inc. |
| Feb 6, 2019 | Oxytocin 30 Units added to NS 500 mL (oxytocin and 0.9% Sodium Chloride) Inje... | Superpotent Drug: product may contain concentrations of oxytocin higher than what is represented ... | Class III | Advanced Pharma Inc. |
| Feb 6, 2019 | Oxytocin 20 Units added to NS 1000 mL (oxytocin and 0.9% Sodium Chloride) Inj... | Superpotent Drug: product may contain concentrations of oxytocin higher than what is represented ... | Class III | Advanced Pharma Inc. |
| Jan 15, 2019 | HEPERAIN 50 mg/50 mL (1mg/mL) Injectable Solution, Heparin Sodium 0.45% Sodiu... | Labeling; Label Error on Declared Strength; label incorrectly states the concentration as 50 mg/5... | Class II | Advanced Pharma Inc. |
| Dec 10, 2018 | Options Rx Anti-Oxidant Oil-Free Sunscreeen (Octinoxate 7.5%, Octisalate 5%, ... | Subpotent Drug:Out of specification for percentage of active pharmaceutical ingredients. | Class III | CBI Laboratories, Inc. |
| Dec 10, 2018 | Advanced Protection Sunscreen spf 30 (Octinoxate 7.5%, Octisalate 5%, Oxybenz... | Subpotent Drug:Out of specification for percentage of active pharmaceutical ingredients. | Class III | CBI Laboratories, Inc. |
| Nov 29, 2018 | Phenylephrine HCl, 1 mg in Sterile Water for Injection, QS 10mL Injectable So... | Labeling: Label Error on Declared Strength: Label incorrectly lists concentration as "10 mcg per ... | Class I | Advanced Pharma Inc. |
| Nov 21, 2018 | Norepinephrine 8 mg (32 mcg/mL) added to 0.9% Sodium Chloride Injection 250 m... | Incorrect excipient: Product was compounded in 250 mL 5% Dextrose instead of 250 mL 0.9% Sodium C... | Class III | QuVa Pharma, Inc. |
| Nov 19, 2018 | Human Chorionic Gonadotropin 3000 IU, Rx only, Pharm D. Solutions 1304 South ... | Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of pro... | Class II | Pharm D Solutions, LLC |
| Nov 2, 2018 | curaplex Epi Safe Kit, 8600-01101, contains:" 1ml Vial of Epinephrine " 1 Ep... | Labeling Incorrect Instructions: This recall has been initiated because the Instructions for Use... | Class II | Bound Tree Medical, LLC |
| Nov 2, 2018 | curaplex Epi Safe Administration and Training Kits, #8600-01100, Contains: 2 ... | Labeling Incorrect Instructions: This recall has been initiated because the Instructions for Use... | Class II | Bound Tree Medical, LLC |
| Nov 2, 2018 | Curaplex Epi Safe Kit, 8600-01102 TRAINING ONLY, Rx Only, Distributed by Sarn... | Labeling Incorrect Instructions: This recall has been initiated because the Instructions for Use... | Class II | Bound Tree Medical, LLC |
| Nov 2, 2018 | Curaplex Epi Kit NOT FOR IV USE, #8600-01120, Epi-Safe Kit 8600-01 120 contai... | Labeling Incorrect Instructions: This recall has been initiated because the Instructions for Use... | Class II | Bound Tree Medical, LLC |
| Nov 1, 2018 | Curaplex Epi Safe Kit, Rx Only, contains: 1mL Vial of Epinephrine, 1 Epi-Safe... | Labeling: Incorrect or missing Lot and/or Exp Date:The Kit is incorrectly labeled as expiring May... | Class III | Bound Tree Medical, LLC |
| Nov 1, 2018 | curaplex Epi Safe Administration and Training Kits # 8600-01100. Kit contains... | Labeling: Incorrect or Missing Lot and/or Exp date: vials of epinephrine within kit 8600-01100 e... | Class II | Bound Tree Medical, LLC |
| Sep 25, 2018 | Progesterone SR 100 mg Capsules, packed in 8,13, 20, 30, 40 or 60 dram screw ... | Labeling Not Elsewhere Classified: Misbranding. | Class III | Right Value Drug Stores, Inc. |
| Sep 25, 2018 | Tadalafil SR 7 mg Capsules packed in 8,13, 20, 30, 40 or 60 dram screw top pi... | Labeling Not Elsewhere Classified: Misbranding. | Class III | Right Value Drug Stores, Inc. |
| Sep 25, 2018 | Progesterone SR 200 mg Capsules, packed in 8,13, 20, 30, 40 or 60 dram screw ... | Labeling Not Elsewhere Classified: Misbranding. | Class III | Right Value Drug Stores, Inc. |
| Sep 25, 2018 | Tadalafil SR 12 mg Capsules packed in 8,13, 20, 30, 40 or 60 dram screw top p... | Labeling Not Elsewhere Classified: Misbranding. | Class III | Right Value Drug Stores, Inc. |
| Sep 10, 2018 | Trimix ST-1 30PA-1.5PH-50A Aqueous Solution Pharm D Solutions, Houston, Texas... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Phenol 7% and Glycerin Aqueous Solution 10 mL Injectable, Pharm D Solutions, ... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Lipo MIC-12 Compound Injectable a) NDC 69699-1603-10; b) 30 mL Stock Solution... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Bi-Mix Injection (Alprostadil 150 mcg/Lidocaine 2 mg/mL), Pharm D Solutions, ... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Calcium Gluconate1% Eyewash 10 mg/mL, 125 mL bottles, Pharm D Solutions, Hou... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Calcium Gluconate 1% Eyewash Oph. Soln, 10 mg/mL, 1000 mL bottles, Pharm D So... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Trimix Papaverine/Phentolamine/Alprostadil 30 mg/1 mg/60 mcg Powder Pharm D S... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | HCG 3000 Unit Powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1738-10 | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | QM-4A Quadmix 5 mL 30 PA-2PH-150A-Atropine 0.4 mg Aqueous Solution, Pharm D S... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Arginine Injections 100 mcg/mL, Pharm D Solutions, Houston, Texas NDC 69699-1... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Calcium Gluconate 10%, 100 mg/mL Injectable, Pharm D Solutions, Houston, Texa... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Zinc Sulfate 1 mg/mL MDV Injectable, Pharm D Solutions, Houston, Texas --- ND... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Vigamox Oph. Solution Pharm D Solutions, Houston, Texas --- NDC 69699-0304-05 | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Trimix T105 PGE/Phentolamine/Papaverine 10 mcg/30 mg/1 mg Injectable Pharm D ... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Magnesium 40 gm/ns 1000 mL IV, Pharm D Solutions, Houston, Texas --- NDC 6969... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | HCG Reconstitued 50,000 IU Injectable, Pharm D Solutions, Houston, Texas --- ... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Sermorelin/Ipamorelin 18 mg/15 mg Powder, Pharm D Solutions, Houston, Texas -... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Glycerin 72% (Lidocaine/Epi 2:1) Injectable, Pharm D Solutions, Houston, Texa... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Sterile Water 50 mL Aqueous Solution, Pharm D Solutions, Houston, Texas --- N... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | 0.9% Sodium Chloride for Injection, 50 mL bags, Pharm D Solutions, Houston, T... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Bi-Mix (Papaverine/Phentolamine 150 mg/5 mg) a) Injectable NDC 69699-1760-15;... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Bi-Mix Injection (Alprostadil 80 mcg/Lidocaine 2 mg/mL) Pharm D Solutions, Ho... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Prostaglandin E1 80 mcg/mL Injectable, Pharm D Solutions, Houston, Texas --- ... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Pyridoxine 100 mg/mL, 30 mL MDV Injectable, Pharm D Solutions, Houston, Texas... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | HCG 50,000 unit/0.3 gm Mannitol Lyophilized Powder Pharm D Solutions, Houston... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Sermorelin/GHRP-2/GHRP-6 Mannitol 9 mg/9 mg/9 mg/300 mg Powder, Pharm D Solut... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Phenol 5% and Glycerin Aqueous Solution 10 mL Injection, Pharm D Solutions, H... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.